Simon M. Schoenbuchner

Simon M. Schoenbuchner

Auto-generated profile, based on publicly available information

Simon M. Schoenbuchner

Medical Research Council (MRC) Elsie Widdowson Laboratory, Cambridge, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2018 in Archives of Public Health
Verified
Journal Article
Open access
PDF file
MMMark Myatt
Mark Myatt
TKTanya Khara
Tanya Khara
SSSimon Schoenbuchner
Simon Schoenbuchner
SPSilke Pietzsch
Silke Pietzsch
CDCarmel Dolan
Carmel Dolan
ABAndré BRIEND
André BRIEND
Wasting and stunting are common. They are implicated in the deaths of almost two million children each year and account for over 12% of disability-adjusted life years lost in young children. Wasting and stunting tend to be addressed as separate issues despite evidence of common causality and the fact that children may suffer simultaneously from both conditions (WaSt). Questions remain regarding the risks associated with WaSt, which children are most affected, and how best to reach them. A database of cross-sectional survey datasets containing data for almost 1.8 million children was compiled. This was analysed to determine the intersection between sets of wasted, stunted, and underweight children; the association between being wasted and being stunted; the severity of wasting and stunting in WaSt children; the prevalence of WaSt by age and sex, and to identify weight-for-age z-score and mid-upper arm circumference thresholds for detecting cases of WaSt. An additional analysis of the WHO Growth Standards sought the maximum possible weight-for-age z-score for WaSt children. All children who were simultaneously wasted and stunted were also underweight. The maximum possible weight-for-age z-score in these children was below − 2.35. Low WHZ and low HAZ have a joint effect on WAZ which varies with age and sex. WaSt and “multiple anthropometric deficits” (i.e. being simultaneously wasted, stunted, and underweight) are identical conditions. The conditions of being wasted and being stunted are positively associated with each other. WaSt cases have more severe wasting than wasted only cases. WaSt cases have more severe stunting than stunted only cases. WaSt is largely a disease of younger children and of males. Cases of WaSt can be detected with excellent sensitivity and good specificity using weight-for-age. The category “multiple anthropometric deficits” can be abandoned in favour of WaSt. Therapeutic feeding programs should cover WaSt cases given the high mortality risk associated with this condition. Work on treatment effectiveness, duration of treatment, and relapse after cure for WaSt cases should be undertaken. Routine reporting of the prevalence of WaSt should be encouraged. Further work on the aetiology, prevention, case-finding, and treatment of WaSt cases as well as the extent to which current interventions are reaching WaSt cases is required.

7 February 2019 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
SSSimon M Schoenbuchner
Simon M Schoenbuchner
CDCarmel Dolan
Carmel Dolan
MMMartha Mwangome
Martha Mwangome
AHAndrew Hall
Andrew Hall
SRStephanie A Richard
Stephanie A Richard
SMSophie Moore
Sophie Moore
The etiologic relationship between wasting and stunting is poorly understood, largely because of a lack of high-quality longitudinal data from children at risk of undernutrition. The aim of this study was to describe the interrelationships between wasting and stunting in children aged <2 y. This study involved a retrospective cohort analysis, based on growth-monitoring records spanning 4 decades from clinics in rural Gambia. Anthropometric data collected at scheduled infant welfare clinics were converted to z scores, comprising 64,342 observations on 5160 subjects (median: 12 observations per individual). Children were defined as “wasted” if they had a weight-for-length z score <–2 against the WHO reference and “stunted” if they had a length-for-age z score <–2. Levels of wasting and stunting were high in this population, peaking at approximately (girls–boys) 12–18% at 10–12 months (wasted) and 37–39% at 24 mo of age (stunted). Infants born at the start of the annual wet season (July–October) showed early growth faltering in weight-for-length z score, putting them at increased risk of subsequent stunting. Using time-lagged observations, being wasted was predictive of stunting (OR: 3.2; 95% CI: 2.7, 3.9), even after accounting for current stunting. Boys were more likely to be wasted, stunted, and concurrently wasted and stunted than girls, as well as being more susceptible to seasonally driven growth deficits. We provide evidence that stunting is in part a biological response to previous episodes of being wasted. This finding suggests that stunting may represent a deleterious form of adaptation to more overt undernutrition (wasting). This is important from a policy perspective as it suggests we are failing to recognize the importance of wasting simply because it tends to be more acute and treatable. These data suggest that stunted children are not just short children but are children who earlier were more seriously malnourished and who are survivors of a composite process.

1 December 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
MBMícheál Ó Breasail
Mícheál Ó Breasail
KWKate A Ward
Kate A Ward
SSSimon M. Schoenbuchner
Simon M. Schoenbuchner
MCMustapha Ceesay
Mustapha Ceesay
MMMichael Mendy
Michael Mendy
APAnn Prentice
Ann Prentice
In pregnancy, changes in maternal calcium (Ca) economy occur to satisfy fetal Ca demand. It is unclear whether maternal mineral reserves facilitate these requirements and no data exist from sub‐Saharan Africa. The aim was to determine skeletal changes with pQCT and bone biochemistry between early second and third trimesters. Pregnant rural Gambians aged 18–45 years (n = 467) participating in a trial of antenatal nutritional supplements (ISRCTN49285450) had pQCT scans and blood collections at mean(SD) 14 (3) and 31 (1) weeks gestation. Outcomes were pQCT: radius/tibia 4% total vBMD, trabecular vBMD, total CSA, 33%/38% radius/tibia cortical vBMD, BMC, total CSA; biochemistry: collagen type 1 cross‐linked β‐C‐telopeptide (β‐CTX), type 1 procollagen N‐terminal (P1NP), parathyroid hormone (PTH) and 1,25(OH)2D. Independent t‐tests tested whether pooled or within‐group changes differed from 0. Multiple regression were performed adjusting for age. Data for change are expressed as mean[CI 2.5, 97.5]%. Radius trabecular vBMD, cortical vBMD and BMC increased by 1.15 [0.55, 1.75]%, 0.41 [0.24, 0.58]%, and 0.47 [0.25, 0.69]%. Tibia total and trabecular vBMD increased by 0.34 [0.15, 0.54]% and 0.46 [0.17, 0.74]%, while tibia cortical vBMD, BMC, and cortical CSA increased by 0.35 [0.26, 0.44]%, 0.55 [0.41, 0.68]% and 0.20 [0.09, 0.31]% respectively. CTX, PTH and 1,25(OH)2D increased by 23.0 [15.09, 29.29]%, 13.2 [8.44, 19.34]%, and 21.0 [17.67, 24.29]%, while P1NP decreased by 32.4 [−37.19, −28.17]%. No evidence of mobilization was observed in the peripheral skeleton. Resorption, while higher in late‐ versus early‐gestation, was lower throughout pregnancy compared to non‐pregnant non‐lactating (NPNL) in the same community. Formation was lower in late pregnancy than in early, and below NPNL levels. This suggests a shift in the ratio of resorption to formation. Despite some evidence of change in bone metabolism, in this population, with habitually low Ca intakes, the peripheral skeleton was not mobilized as a Ca source for the fetus.

23 August 2017 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
SSSimon M Schoenbuchner
Simon M Schoenbuchner
JPJohn Pettifor
John Pettifor
Shane NorrisShane Norris
Shane Norris
LMLisa K Micklesfield
Lisa K Micklesfield
APAnn Prentice
Ann Prentice
KWKate A Ward
Kate A Ward
There are no longitudinal pQCT data of bone growth and development from sub-Saharan Africa, where rapid environmental, societal, and economic transitions are occurring, and where fracture rates are predicted to rise. The aim of this study was to compare skeletal development in black and white South African adolescents using longitudinal data from the Birth to Twenty study. The Birth to Twenty Bone Health subcohort consisted of 543 adolescents (261 [178 black] girls, 282 [201 black] boys). Annual pQCT measurements of the radial and tibial metaphysis and diaphysis were obtained between ages 12 and 22 years (distal metaphysis: cross-sectional area [CSA] and trabecular bone mineral density [BMD]; diaphysis: total and cortical CSA, cortical BMD, and polar stress-strain index [SSIp]). Age at peak height velocity (APHV) was calculated to account for differences in maturational timing between ethnic groups and sexes. Mixed-effects models were used to describe trajectories for each pQCT outcome. Likelihood-ratio tests were used to summarize the overall difference in trajectories between black and white participants within each sex. APHV (mean ± SD years) was similar in black (11.8 ± 0.8) and white (12.2 ± 1.0) girls, but delayed in black (14.2 ± 1.0) relative to white boys (13.3 ± 0.8). By 4 years post-APHV, white adolescents had significantly greater cortical CSA and SSIp than black adolescents at the radius. There were no significant differences at the radial metaphysis but there was some divergence, such that black adolescents had greater radial trabecular BMD by the end of follow-up. At the tibia, white adolescents had lower diaphyseal CSA and SSIp, and greater metaphyseal CSA. There was no ethnic difference in tibial trabecular BMD. There are ethnic differences in bone growth and development, independent of maturation, in South African adolescents. This work gives new insights into the possible etiology of childhood fractures, which occur most commonly as peripheral sites. © 2017 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.

1 May 2025 in Health Technology Assessment
Verified
Journal Article
Open access
CWCherry-Ann Waldron
Cherry-Ann Waldron
PPPhilip Pallmann
Philip Pallmann
SSSimon Schoenbuchner
Simon Schoenbuchner
DHDebbie Harris
Debbie Harris
LBLucy Brookes-Howell
Lucy Brookes-Howell
ECEnitan D Carrol
Enitan D Carrol
Background: Procalcitonin is a biomarker specific for bacterial infection, with a more rapid response than other commonly used biomarkers, such as C-reactive protein, but it is not routinely used in the National Health Service. Objective: To determine if using a procalcitonin-guided algorithm may safely reduce duration of antibiotic therapy compared to standard of care in hospitalised children with suspected or confirmed infection. Design: A pragmatic, multicentre, open-label, parallel two-arm, individually randomised controlled trial with internal pilot phase, qualitative study and health economic evaluations. Setting: Paediatric wards or paediatric intensive care units within children’s hospitals (n = 6) and district general hospitals (n = 9) in the United Kingdom. Participants: Children aged between 72 hours and 18 years admitted to hospital and being treated with intravenous antibiotics for suspected or confirmed bacterial infection. Interventions: Procalcitonin-guided algorithm versus usual standard care alone. Main outcome measures: Coprimary outcomes were duration of intravenous antibiotic use and a composite safety measure. Results: Between 11 June 2018 and 12 October 2022, 1949 children were recruited: 977 to the procalcitonin group [427 female (43.7%), 550 male (56.3%)], and 972 to the usual care group [478 female (49.2%), 494 male (50.8%)]. Duration of intravenous antibiotics was not significantly different between the procalcitonin group (median 96.0 hours) and the usual care group (median 99.7 hours) [hazard ratio = 0.96 (0.87, 1.05)], and the procalcitonin-guided algorithm was non-inferior to usual care [risk difference = −0.81% (95% confidence interval upper bound 1.11%)]. At clinical review, a procalcitonin result was available for 81.8% of the time, which was considered as part of clinical decision-making 66.6% of the time, and the algorithm was adhered to 57.2% of the time. Incremental cost-effectiveness ratio per duration of intravenous antibiotics hour avoided from bootstrapped samples was £467.62 per intravenous antibiotic hour avoided. Cost analysis of complete cases was also higher in the procalcitonin arm for all age groups, and for children aged 5 years and over. The intervention is not cost-effective as it is more expensive with no significant improvement in intravenous antibiotic duration. Limitations: Robust antimicrobial stewardship programmes were already implemented in the lead recruiting sites, and adherence to the algorithm was poor. Clinicians may be reluctant to adhere to biomarker-guided algorithms, due to unfamiliarity with interpreting the test result. Conclusions: In children hospitalised with confirmed or suspected bacterial infection, the addition of a procalcitonin-guided algorithm to usual care is non-inferior in terms of safety, but does not reduce duration of intravenous antibiotics, and is not cost-effective. In the presence of robust antimicrobial stewardship programmes to reduce antibiotic use, a procalcitonin-guided algorithm may offer little added value. Future work: Future trials must include an implementation framework to improve trial intervention fidelity, and repeated cycles of education and training to facilitate implementation of biomarker-guided algorithms into routine clinical care. Trial registration: This trial is registered as ISRCTN11369832. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 15/188/42) and is published in full in Health Technology Assessment; Vol. 29, No. 16. See the NIHR Funding and Awards website for further award information.

25 March 2018 in Annals of the New York Academy of Sciences
Verified
Journal Article
Open access
PDF file
SSSimon M. Schoenbuchner
Simon M. Schoenbuchner
SMSophie E. Moore
Sophie E. Moore
WJWilliam Johnson
William Johnson
MNMohammed Ngum
Mohammed Ngum
BSBakary Sonko
Bakary Sonko
KWKate A. Ward
Kate A. Ward
Adolescents may be particularly susceptible to malnutrition owing to the energy and nutrient costs of the pubertal growth spurt. Here, our aim is to compare differences in selected markers of nutritional status between adolescents and adults in rural Gambia. The Keneba Biobank collects cross‐sectional data and samples for all consenting individuals resident in the West Kiang region of the Gambia. For this study, participants between the ages of 10 and 40 years were selected (n = 4201, females 2447). Height, body mass index, body composition, hemoglobin concentration, fasting glucose concentration, and blood pressure were compared using linear regression models adjusting for age, parity, season of measurement, and residence, across three age groups: early adolescent (10–14.9 years), late adolescent (15–19.9 years), and adult (20–39.9 years). Adolescents, particularly early‐adolescent girls and boys, were shorter, lighter, and leaner than adults. By late adolescence, differences were smaller, particularly in girls where, notably, the prevalence of overweight, hypertension, and impaired fasting glucose was low. Given the importance of maternal health for reproductive outcomes and intergenerational health, the results of the study, albeit with limited biomarkers available, indicate that adolescent girls are no more compromised than adult women or males from the same population.